Cargando…

A Novel Multi-Target Mu/Delta Opioid Receptor Agonist, HAGD, Produced Potent Peripheral Antinociception with Limited Side Effects in Mice and Minimal Impact on Human Sperm Motility In Vitro

Pain is a common clinical symptom among patients. Although various opioid analgesics have been developed, their side effects hinder their application. This study aimed to develop a novel opioid analgesic, HAGD (H-Tyr-D-AIa-GIy-Phe-NH(2)), with limited side effects. In vivo studies on mouse models as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fangfang, Yue, Feng, Zhang, Wei, Xu, Biao, Wang, Yiqing, Zhang, Xuehong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824695/ https://www.ncbi.nlm.nih.gov/pubmed/36615612 http://dx.doi.org/10.3390/molecules28010427

Ejemplares similares

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012)

Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice
por: Negus, S. Stevens, et al.
Publicado: (2023)

Delta opioid receptor on equine sperm cells: subcellular localization and involvement in sperm motility analyzed by computer assisted sperm analyzer (CASA)
por: Albrizio, Maria, et al.
Publicado: (2010)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
por: Reichenbach, Zachary W., et al.
Publicado: (2022)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
por: Lattanzi, Roberta, et al.
Publicado: (2018)

5-Benzyl substituted 14-methoxymetopon, a high affinity μ opioid receptor agonist with potent antinociceptive activity in mice
por: Spetea, Mariana, et al.
Publicado: (2008)

The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist
por: Montes, Guilherme Carneiro, et al.
Publicado: (2017)

Chronic Ethanol Consumption in Rats Produces Opioid Antinociceptive Tolerance through Inhibition of Mu Opioid Receptor Endocytosis
por: He, Li, et al.
Publicado: (2011)

Interaction between Mu and Delta Opioid Receptor Agonists in an Assay of Capsaicin-Induced Thermal Allodynia in Rhesus Monkeys
por: Negus, S. Stevens, et al.
Publicado: (2012)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Synthesis, Biological, and Structural Explorations of New Zwitterionic Derivatives of 14-O-Methyloxymorphone, as Potent μ/δ Opioid Agonists and Peripherally Selective Antinociceptives
por: Spetea, Mariana, et al.
Publicado: (2018)

PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016)

Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice
por: Chao, Po-Kuan, et al.
Publicado: (2019)

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2020)

MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys
por: Aceto, Mario D., et al.
Publicado: (2012)

Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia
por: Dripps, Isaac J., et al.
Publicado: (2020)

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity
por: Greedy, Benjamin M., et al.
Publicado: (2013)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D(2) Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
por: Vasudevan, Lakshmi, et al.
Publicado: (2019)

Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene
por: Chen, Shiou-Lan, et al.
Publicado: (2010)

The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
por: Hill, Rob, et al.
Publicado: (2018)

The induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice
por: McDonnell, Christina, et al.
Publicado: (2017)

Recent Molecular Insights into Agonist-specific Binding to the Mu-Opioid Receptor
por: Zádor, Ferenc, et al.
Publicado: (2022)

Role of Mu and Delta Opioid Receptors in the Nucleus Accumbens in Cocaine-Seeking Behavior
por: Simmons, Diana, et al.
Publicado: (2009)

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
por: Ong, Edmund W., et al.
Publicado: (2014)

Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits
por: Wang, Dong, et al.
Publicado: (2018)

Kappa but not delta or mu opioid receptors form homodimers at low membrane densities
por: Cechova, Kristina, et al.
Publicado: (2021)

Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects
por: Requana Aradas, Ariadna, et al.
Publicado: (2023)

Quantitative proteomic analysis reveals the effects of mu opioid agonists on HT22 cells
por: Zhang, Xutong, et al.
Publicado: (2023)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

Identification of a Potent and Selective 5-HT(1A) Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity
por: Linciano, Pasquale, et al.
Publicado: (2020)

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists
por: Szűcs, Edina, et al.
Publicado: (2020)

Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors
por: Neubert, John K, et al.
Publicado: (2007)

New Insights on Expression and Function of Mu and Delta Opioid Receptors in Mouse Gastrointestinal Tract
por: Feng, Bin
Publicado: (2020)

Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons
por: He, Xinyi Jenny, et al.
Publicado: (2021)

In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists
por: Pradhan, Amynah A. A., et al.
Publicado: (2009)

Effects of delta-opioid receptor agonist pretreatment on the cardiotoxicity of bupivacaine in rats
por: Wang, Chenran, et al.
Publicado: (2022)

Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors
por: Zaveri, Nurulain T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7a3qn1q80ccnbatevp2hpe6mie